EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review

Pablo Rábano-Suárez, Natalia Del Campo, Isabelle Benatru, Caroline Moreau, Clément Desjardins, Álvaro Sánchez-Ferro, Margherita Fabbri iD

Movement Disorders · 2025-02 · 40 (2) · 184-203

DOI: 10.1002/mds.30056 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Movement Disorders, online erschienen am 29.11.2024. Verfasst von Pablo Rábano-Suárez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario 12 de Octubre, Madrid, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Disease Progression. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outcomes derived from digital health technologies (DHTs) are promising candidate markers for monitoring Parkinson's disease (PD) progression. They have the potential to represent a significant shift in clinical research and therapeutic development in PD. However, their ability to track disease progression is yet to be established. This systematic review aimed to identify digital biomarkers capable of tracking early PD progression (disease duration

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDisease ProgressionHumansBiomarkers

Stichwörter der Autor:innen

Parkinson's diseaseclinical trialsdigital health technologydisease progressionearly stage

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Centre, NS-Park/FCRIN Network and NeuroToul COEN Center, Toulouse University Hospital, INSERM, University of Toulouse 3, Tou…
  • Department of Neurology, University Hospital of Poitiers, Poitiers, France.
  • INSERM, CHU de Poitiers, Centre d'Investigation Clinique CIC1402, University of Poitiers, Poitiers, France.
  • Department of Neurology, LICEND COEN Center, Lille Neuroscience and Cognition, INSERM UMR S1172, CHU Lille, University Lille, Lille, France.
  • Department of Neurology, Rothschild Foundation Hospital, Paris, France.

ORCID-Profile: Margherita Fabbri

Zitieren

APA

Rábano-Suárez, P., Del Campo, N., Benatru, I., Moreau, C., Desjardins, C., Sánchez-Ferro, Á., & Fabbri, M. (2025). Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review. Movement Disorders, 40(2), 184-203. https://doi.org/10.1002/mds.30056

Vancouver

Rábano-Suárez P, Del Campo N, Benatru I, Moreau C, Desjardins C, Sánchez-Ferro Á, et al. Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review. Movement Disorders. 2025;40(2):184-203. doi:10.1002/mds.30056

BibTeX
@article{RbanoSurez2025,
  author = {Rábano-Suárez, Pablo and Del Campo, Natalia and Benatru, Isabelle and Moreau, Caroline and Desjardins, Clément and Sánchez-Ferro, Álvaro and Fabbri, Margherita},
  title = {Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {2},
  pages = {184--203},
  doi = {10.1002/mds.30056}
}
Kostenlos starten →